May 11, 2022

Combined 18 F-FDG PET/CT Radiomics and Sarcopenia Score in Predicting Relapse-Free Survival and Overall Survival in Patients With Esophagogastric Cancer

Clinical nuclear medicine
Reut Anconina, Claudia Ortega, Ur Metser, Zhihui Amy Liu, Elena Elimova, Michael Allen, Gail E Darling, Rebecca Wong, Kirsty Taylor, Jonathan Yeung, Eric X Chen, Carol J Swallow, Raymond W Jang, Patrick Veit-Haibach
CONCLUSIONS: PET and CT radiomics derived from combined PET/CT integrated with clinicopathological parameters and sarcopenia measurement might improve outcome prediction in patients with nonmetastatic esophagogastric adenocarcinoma.